AstraZeneca COVID-19 Vaccine Linked To Another Rare Fatal Blood Clotting Disorder VITT from bangla new video co 2015u09ac u09b9u099f u09acu09beu0982u09b2 u0997u09c7u09b0u09beu09aeu09c7u09b0 u09adu09bfu09a1u09bfu0993gla blue film Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 1:46 👁 View: 2.5M times ✓ Published: 16-May-2024
Description: A team of researchers has claimed that British-Swedish pharma giant AstraZeneca's COVID-19 vaccine has been found to raise the risk of VITT or vaccine-induced immune thrombocytopenia and thrombosis, a rare but fatal blood clotting disorder. This came after the company admitted that the vaccine, made in collaboration with Oxford University, can, in very rare cases, cause Thrombotic Thrombocytopenic Syndrome (TTS).<br/>
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)